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Objective: The trauma caused during cochlear implant insertion can lead to cell death and a loss of re-
sidual hair cells in the cochlea. Various therapeutic approaches have been studied to prevent cochlear
implant-induced residual hearing loss with limited success. In the present study, we show the efﬁcacy of
mild to moderate therapeutic hypothermia of 4 to 6 C applied to the cochlea in reducing residual
hearing loss associated with the electrode insertion trauma.
Approach: Rats were randomly distributed in three groups: control contralateral cochleae, normothermic
implanted cochleae and hypothermic implanted cochleae. Localized hypothermia was delivered to the
middle turn of the cochlea for 20 min before and after implantation using a custom-designed probe
perfused with cooled ﬂuorocarbon. Auditory brainstem responses (ABRs) were recorded to assess the
hearing function prior to and post-cochlear implantation at various time points up to 30 days. At the
conclusion of the trials, inner ears were harvested for histology and cell count. The approach was
extended to cadaver temporal bones to study the potential surgical approach and efﬁcacy of our device.
In this case, the hypothermia probe was placed next to the round window niche via the facial recess or a
myringotomy.
Main results: A signiﬁcant loss of residual hearing was observed in the normothermic implant group.
Comparatively, the residual hearing in the cochleae receiving therapeutic hypothermia was signiﬁcantly
conserved. Histology conﬁrmed a signiﬁcant loss of outer hair cells in normothermic cochleae receiving
the surgical trauma when compared to the hypothermia treated group. In human temporal bones, a
controlled and effective cooling of the cochlea was achieved using our approach.
Signiﬁcance: Collectively, these results suggest that therapeutic hypothermia during cochlear implan-
tation may reduce traumatic effects of electrode insertion and improve conservation of residual hearing.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Conservation of residual hearing by reducing cochlear trauma
has always been an important goal during inner ear surgeries,
especially during cochlear implantation (CI). Patients with residual
hearing are now being implanted to take advantage of bimodalnstitute, 1600 NW 10th Ave,
u).
B.V. This is an open access article uelectroacoustic stimulation (EAS) (Irving et al., 2014). The Food and
Drug Administration (FDA)-approved indications for CI now allow
bilateral implants in young children (Carlson et al., 2015; Ching
et al., 2014), in whom residual hearing levels may be difﬁcult to
ascertain (Tharpe and Sladen, 2008). Furthermore, in recent years,
novel CI electrode designs have improved efﬁciency and perfor-
mance by locating stimulation sites closer to spiral ganglion neu-
rons and deeper into the scala tympani. As a result, in the future,
the number of CI/EAS recipients with some degree of usable hear-
ing is likely to increase. Depending upon the insertion depth andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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inﬂammation and oxidative stress leading to neural degeneration,
hair cell loss and loss of residual hearing (Eshraghi et al., 2005;
Wardrop et al., 2005). The nature of cochlear electrode insertion
trauma has been characterized both in animal models and in
temporal bone studies. Previous research has demonstrated the
relationship between device-speciﬁc CI electrodes and surgical
techniques with cochlear trauma (Adunka et al., 2005; Ahmad et al.,
2012; Briggs et al., 2001). Auditory brainstem response (ABR)
studies in animal models have observed signiﬁcant increase in
hearing thresholds within 7 days of implantation trauma (Balkany
et al., 2005) and can be a result of both the intrinsic and extrinsic
cell death signaling pathways (Bas et al., 2015). The loss of residual
hearing due to electrode-induced trauma (EIT) can negatively
impact the learning ability and speech recognition in younger pa-
tients. As such the importance of protecting residual hearing during
and after implantation has grown proportionately. To reduce
trauma-associated cellular response, reﬁnements in surgical tech-
niques and neuroprotective drug-eluting electrodes are being
investigated (Dinh et al., 2008; Friedland and Runge-Samuelson,
2009; James et al., 2008; Jolly et al., 2010; Van De Water et al.,
2010; Vivero et al., 2008). While surgical techniques and electrode
designs have been advanced, residual hearing is still lost in many
cochlear implant patients (Balkany et al., 2006; Kiefer et al., 2004).
The present study tested the hypothesis that localized thera-
peutic hypothermia applied to the cochlea prior to implantation
can protect hair cells (HC) and neurons and hence may preserve
residual hearing. Mild to moderate hypothermia is a promising
neuroprotective intervention when induced during or after a cen-
tral nervous system injury (Cappuccino et al., 2010; Dietrich et al.,
2009; Kawai et al., 2000; Levi et al., 2010; Matsui et al., 2006).
When localized and administered prior to trauma, these effects
may be enhanced with little adverse effects on other biological
phenomena or immune response (Purdy et al., 2013; Tzen et al.,
2013). Mild therapeutic hypothermia, deﬁned as a temperature
decrease of 4e6 C below body temperature, has the potential to
reduce or prevent oxidative stress (Balkany et al., 2005; Henry and
Chole, 1984; Shintani et al., 2010). Prior literature, both from animal
studies and clinical trials, has shown protective effects of thera-
peutic hypothermia on ischemic and traumatic injuries to neurons
(Levi et al., 2010; Ohta et al., 2007; Shintani et al., 2010; Yanamoto
et al., 1999; Yokobori et al., 2011) in cases of mild traumatic brain
injury (mTBI), seizures (Atkins et al., 2010), ischemia and inﬂam-
matory response (Cappuccino et al., 2010; Kawai et al., 2000; Levi
et al., 2010; Matsui et al., 2006) after cardiac arrest, and related to
spinal cord injuries (Cappuccino et al., 2010; Dietrich et al., 2009).
Unfortunately, systemic hypothermia has multiple side effects on
functioning of organs and organ systems including impairment to
immune response, higher infection, altered effects of other drugs
and compromising vascular function. These adverse effects restrict
its use in clinical setting, and make it challenging to utilize hypo-
thermia for preserving sensory functions of the inner ear.
That temperature is an important parameter and inﬂuences
cochlear responses has been long known (Brown et al., 1983;
Liberman and Dodds, 1984; Ohlemiller and Siegel, 1992, 1994)
with demonstrated beneﬁt of applied hypothermia (Henry and
Chole, 1984; Watanabe et al., 2001). To test the beneﬁcial effects
of localized hypothermia in otoprotection, we designed a custom
device to cool the cochlea that does not require any modiﬁcations
to the current CI surgical approach. Direct comparisons were made
between hearing thresholds post-surgery in normothermic and
hypothermic-treated cochleae in normal hearing rats subjected to
EIT. We also carried out a detailed histological study at the end of
the long-term implantation and observed signiﬁcant otoprotection
with hypothermia.2. Methods
2.1. Animal preparation and surgical approach
The use of Brown Norway rats with normal hearing in this study
was approved by the University of Miami Animal Care and Use
Committee and was in compliance with USDA and NIH Guidelines
for the Care and Use of Laboratory Animals. The animals were
anesthetized with an initial intraperitoneal injection of Ketamine
and Xylazine (22e60 and 5e10mg/kg respectively) andmaintained
with supplemental doses. Lidocaine HCl 1% was used for local
analgesia prior to surgical incision. Withdrawal reﬂex was
measured by extension of one leg and pinching the web of skin
between the toes or pinching the ear. A positive reﬂex was indi-
cated by ﬂexion of the limbwith toe, paw pinch ormovement of the
head or whiskers with ear pinch. Once anesthetized, a bland, sterile
ophthalmic base ointment was applied to corneas to prevent eye
dryness. The skin over the skull and behind the ears was shaved,
and prepped with Betadine scrub. All surgical procedures were
performed under aseptic conditions. For the approach to the inner
ear organs, a post-auricular incision was made extending from the
dorsal skin defect down behind the ear to terminate approximately
over the posterior edge of the mandible. The soft tissues were
dissected to expose the temporal bone over the bulla. A small defect
in the bone of the bulla was created using the tip of a scalpel blade
or a hand-held micro-drill to expose both the round window
membrane niche and the lateral bony wall of the cochlea adjacent
to the niche. Electrode trauma to the cochlea was accomplished by
the insertion of an electrode analog into the scala tympani via the
round window to a depth of 5 mm. The electrode analog was
0.28 mm monoﬁlament as described previously (Bas et al., 2012,
2015) to allow for insertion in the smaller scala tympani of the
rat. The site around the electrode was secured by packing with a
graft of fascia obtained locally from the site of the surgical approach
to the bulla. Once the placement and stability of the electrode
analog were established, the defect in the ventro-lateral wall of the
temporal bone bulla was covered with carboxylate cement, with
care taken not to allow the cement to enter into the bulla. A sub-
cuticular closure was made using vicryl absorbable sterile sutures
and the skin was closed with vicryl absorbable sutures. A topical
antibiotic silver sulfadiazine 1% or Bacitracin Zinc was applied to
the wound sites. To prevent post-op dehydration the animals
received IP or SC injection of sterile Ringer's solution (up to 1 mL).
To prevent post-operative pain, buprenorphine (Buprenex,
0.05 mg/kg) was given once at the time of surgery and sequential
dosages were provided for 48 h to aid recovery. To prevent hypo-
thermia post-op, the animal holding/recovery cages where placed
on water-circulating heating pads. There were three experimental
groups: in the ﬁrst group, the left ear was implanted under
normothermic condition and in the second group, therapeutic hy-
pothermia (cooling by 3e6 C measured at the round window) was
provided using the newly developed hypothermia device. The right
contralateral ear always served as the intra-animal control.
2.2. Delivery of therapeutic hypothermia
A novel copper hypothermia probe attached to a custom ther-
moelectric Peltier device was placed in the middle ear adjacent to
the cochlea under direct visualization. Fluorocarbon cooled by the
Peltier system was used as the refrigerant, and circulated through
the metal probe. In acute experiments (n ¼ 7), the temperatures at
the apex and the basal turn of the cochlea were measured using
(QTI Sensing Solutions' T320/E320) microthermistors over time.
The temperature of the cochlea was reduced by a 5e6 C with our
device (Fig. 1) and cooling was maintained within ±0.3 C over the
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we tested the following protocol for chronic experiments: localized
hypothermia was applied for 20 min before, and for 20 min after
cochlear implantation for a total hypothermia duration of 40 min.
2.3. Measurement of hearing thresholds: auditory brainstem
responses (ABR)
All animals were naïve with normal hearing prior to surgery.
ABRs were measured for acoustic tones between 0.5 and 32 kHz
before surgery to determine the pre-surgical hearing thresholds
(Fig. 2). On average the thresholds were ~40 dB SPL at 0.5 kHz and
1 kHz, 30 dB at 2 kHz, 15 dB at 4 kHz, 8 kHz, and 16 kHz, and
30 dB at 32 kHz. ABRs were also measured at various time points
post-surgery up to 30 days in the contralateral control, normo-
thermic implanted and hypothermia-treatment implanted ears and
compared to respective pre-surgical thresholds. The changes in
residual hearing with electrode insertion trauma were tested on
the frequencies of 0.5, 1, 2, 4, 8, 16, 24, and 32 kHz using 1000
sweeps of tone bursts of a rate of stimulation of 21.1 Hz ampliﬁed
using an Opti-Amp bioampliﬁer from Intelligent Hearing Systems
(IHS, Miami, FL) connected to the Smart EP system. Recording
negative electrodes were attached to the each ipsilateral superior
post auricular area and with a positive reference electrode to the
vertex. A ground electrode was inserted subcutaneously on the left
leg. The ipsilateral ABR information was assessed bilaterally by
averaging 1000 samples at each interval starting from a level of
80 dB SPL tone bursts and decreasing by 10 dB steps until no
identiﬁable ABR responsewas present at each frequency. Threshold
was deﬁned as the minimum stimulating level where an ABR
response was both identiﬁable and repeatable. The hearing func-
tionwas compared between the three groups: cochleae that did not
receive hypothermia during surgery (normothermic trauma-only
group, n ¼ 7), cochleae that received localized mild hypothermia
(hypothermia treated group, n ¼ 7) and the contralateral cochleae
of each animal (control group, n¼ 14). Two animals did not survive
past 14 days and 4 animals were not sampled at day 14. ABR in-
formation was additionally reviewed by two blinded investigators
for accuracy with no knowledge of the animal group classiﬁcation.
2.4. Histology
At the conclusion of the trials, inner ears were harvested and
ﬁxed with 4% paraformaldehyde for histologic evaluation of theFig. 1. (A) shows placement of the hypothermia probe in contact with an excised rat left co
temperature measurement are highlighted. Fluorocarbon cooled by an external peltier elem
artery, OW-oval window, S-stapes. (B) With the custom-designed thermoelectric cooler and
within 10 min. The temperature was maintained for 20 min prior to insertion of the electrod
of the cochleae over 10 min. Inset shows the level of cooling achieved at the round windoorgan of Corti (OC). The ﬁxed explants were washed three times in
PBS the OC was dissected from the bony capsule and subsequently
incubated in 5% normal goat serum (Sigma Aldrich, MO) and 1%
Triton X-100 (Sigma Aldrich) in PBS for 30 min at 25 C. OC speci-
mens were then incubated with FITC-labeled phalloidin (Sigma-
Aldrich) for 45 min at 25 C and washed three times. The OC were
placed in DAPI solution to label the nuclei for 5 min and washed
three times. After washing, these OC explants were mounted on a
glass slide and viewed under a confocal microscope Zeiss LSM 700.
Stereocilia bundles of HCs stained with phalloidin-FITC were
recognized. A HC was counted if it possessed an intact cuticular
plate with an intact stereociliary bundle. Total HCs were counted
for the apex, middle and basal images taken from regions of the OC
explants and expressed as percentage of HCs lost on each. Each
image count was additionally veriﬁed by two blinded investigators
individually selecting from a non-descript total set. Counts were
then segregated into their respective groups. The HC count was
compared between the three groups: normothermic, hypothermic
and control contralateral cochleae.2.5. Surgical approach in human temporal bone
The hypothermia device and probe were tested on human
temporal bones (n ¼ 3) to test the feasibility of achieving mild to
moderate therapeutic hypothermia during surgery. The bone was
placed on a heat pad to maintain it near room temperature. The
facial recess was approached by canal wall up mastoidectomy. The
mucosa and bone of the round window niche were taken down
using 1 mm coarse diamond burr and instrument. The round
windowmembranewas visualized and pierced using Rosen needle.
The hypothermia probe was placed anteroinferior to the round
window via a myringotomy. The bones were perfused via the round
window with egress via a cochleostomy on the apical surface with
water heated at 45 C that translated into approximate 36 C
measured near or at the round window and at a hole drilled on the
inside of the bone to expose the cochlea apex. The custom device
with probe placed near the promontory was used to lower the
temperature by 4e6 C at the measuring locations. A micro-
thermistor was placed on the surface of the mastoid to measure
temperature over time. Two other microthermistors were placed
on the cochleae: one at on the bone covering apical surface (via
middle fossa approach) and another near the round window
membrane.chlea. The inserted electrode analog and a thermistor placed at the round window for
ent is circulated through the copper tip of the probe. RW-round window, SA-stapedial
probe positioned anteroinferior to the RW, the cochleae were cooled between 4e6 C
e analog. Hypothermia was maintained for further 20 min prior to a gradual rewarming
w measured prior to electrode insertion in animals undergoing chronic insertion.
Fig. 2. Shows the mean ± S.D. of the auditory brainstem responses at 0.5 (3A1) 32 (3A8) kHz tones were recorded up to 30 days following cochlear implant surgery (at day 0) in
rats. The responses were compared for three groups: normothermic cochleae receiving EIT (red, n ¼ 7 except for days 14, where n ¼ 5 and 28, where n ¼ 6), hypothermic cochleae
receiving EIT (blue, n ¼ 7 except for days 14, where n ¼ 5 and 28, where n ¼ 6) and non-operated, contralateral control cochleae (black, n ¼ 14 except for days 14, where n ¼ 10 and
28, where n ¼ 12). The electrode was chronically implanted and remained in place throughout the duration. 3B) shows the results represented as mean ± S.D. of the threshold shift
on days 1, 3, 7, 14 and 28 following electrode insertion from intranimal pre-surgical thresholds.
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The results were assessed by using two-way ANOVA imple-
mented in MATLAB and presented as mean ± S.D. For each fre-
quency, group was the between subject factor, whereas decibels
was the within-subject factor. Not signiﬁcant values are repre-
sented with ns, values of p < 0.05 are represented by *, values of
p < 0.01 are represented by ** and values of p < 0.001 are repre-
sented by ***.3. Results
With the current surgical approach and placement of the hy-
pothermia probe in close proximity to the cochlear wall, we could
successfully achieve 4e6 C of cooling required for therapeutic
hypothermia in rat cochleae within 5e8 min (Fig. 1). The design of
our device and its efﬁcacy were tested in two acute experiments
(Fig. 1B). The temperature was maintained within ±0.3 C over the
duration of the experiments. In the present set of experiments,
hypothermiawas maintained for 20 min prior to and post electrode
insertion for a total of 40 min. Contralateral cochleae were used as
an intra-animal reference.3.1. Hypothermia prevented a signiﬁcant elevation in hearing
thresholds following cochlear implant trauma
In order to investigate the efﬁcacy of therapeutic hypothermia,
we studied the changes in hearing threshold evoked post cochlear
implantation in normothermic and hypothermic-treated implanted
cochleae (Fig. 2). The results show the comparison of ABRs between
the three groups at different frequency locations (mean ± S.D). For
example, at frequency location of 16 kHz a signiﬁcant increase in
hearing thresholds was observed at day 1 post-surgery (two-way
ANOVA, p < 0.01, Fig. 2A6). In the normothermic implanted
cochleae, the signiﬁcant loss of residual hearing post-surgical
trauma persisted until 28 days. The hearing threshold increased
by 60 ± 20 dB (n ¼ 7) on the day after surgical implantation and it
remained elevated for up to 28-days (an elevation of 65 ± 27 dB
over pre-surgical levels). In comparison, thresholds in the
hypothermic-implanted cochleae increased by 35 ± 26 dB on the
day after surgical implantation. Starting day 3 post-implantation, a
recovery was observed with the hearing thresholds returning to
pre-surgical levels by day 28 (elevation of 4 ± 15 dB). The hearing
thresholds of the contralateral cochleae did not change signiﬁcantly
over the duration of the experiments (19 ± 7 dB at day 28 compared
I. Tamames et al. / Hearing Research 339 (2016) 32e3936to 14 ± 6 dB measured at the day before surgery). All ABR mea-
surements were carried out in euthermic conditions (37 C body
temperature).
The effects of EIT on residual hearing and the efﬁcacy of thera-
peutic hypothermia were consistent across multiple frequency lo-
cations. ABRs were measured between 500 Hz (Fig. 2A1) and
32 kHz (Fig. 2A8) for changes in hearing threshold evoked post
cochlear implantation in normothermic and hypothermic-treated
implanted cochleae. These hearing threshold were repeated on
day 1, 3, 7, 14 and 28. The results similarly display increased hearing
threshold (two-way ANOVA, p < 0.01) for normothermic cochleae
after surgical implantation with an average increase of 56 ± 12 dB.
The hearing threshold remained elevated with an average change
of 48 ± 24 dB at day 28 (as compared to pre-surgical levels). On the
contrary, the hypothermic treated cochleae had post-surgical in-
crease in hearing thresholds ~35 ± 24 dB and displayed a signiﬁcant
recovery at 28 days (a non signiﬁcant change of 7 ± 13 dB compared
to pre-surgical levels). The contralateral control cochleae did not
show signiﬁcant changes or progressive loss of residual hearing at
any frequency (5 ± 9 dB at day 28 compared to 2 ± 7 dB measured
pre-surgical). Fig. 2B shows the same results as a threshold shift in
residual hearing over pre-surgical levels measured at post-implant
days 1, 3, 7, 14 and 28.
Hearing threshold measured in the normothermic and
hypothermia-treated groups were normalized with respect to
intra-animal control, contralateral cochleae that were not subjected
to any surgery or treatment. Fig. 3 shows the averaged change in
the two groups measured at various frequencies and over the
duration of the experiment. In normothermic implanted cochleae, a
signiﬁcant loss of residual hearing is observed across all frequencies
including at the lower frequencies corresponding to apical sites
within the cochlea. Comparatively, the hypothermia-treated co-
chlea recovered signiﬁcantly starting day 3 and had hearing
thresholds near normal by day 28. In present experiments, the
electrode analog was inserted at the round window and approxi-
mately to a depth of 5 mm. The placement of the electrode and the
depth of insertion were estimated by using frequency representa-
tion in the rat cochlea derived in a previous study (Muller, 1991).
The approximate electrode position is visualized in Fig. 3 to high-
light the primary site of traumatic injury.Fig. 3. Shows hearing threshold in hypothermia-treated (blue) and normothermic (red) EIT c
tested frequency (0.5, 1, 2, 4, 8, 16, 24 and 32 kHz) and the days at which residual hearing w
approximate site of insertion and length of the inserted electrode are highlighted.3.2. Hypothermia prevented outer hair cell loss following EIT
Cochleae were harvested at day 30 for histologic evaluation of
the OC. Typical photomicrographs from the middle segment of the
cochlea showed stereocilia bundles of HCs stained with phalloidin-
FITC and nuclei stained with DAPI. Contralateral, control cochlea
showed little or no evidence of hair cell loss and normal OHC and
IHC morphology (Fig. 4A). As shown in Fig. 4b, a signiﬁcant loss of
the outer hair cells was observed in the normothermic cochlea
when compared with hypothermia-treated cochlea. Hypothermia
preserved the outer hair cells as seen in the photomicrographs
(Fig. 4c). The inner hair cells were signiﬁcantly less affected in all
the samples, with a small but not signiﬁcant loss in normothermic-
implanted cochleae.
Quantiﬁcation analyses of the microphotographs show an
average outer hair cell loss of 39.5% of normothermic samples
compared to 4.8% loss in hypothermia treated cochleae (Fig. 5A).
Furthermore based on distance, we divided the cochlear samples
into three regions: the basal region encompassing high frequencies
up to 24 kHz, themiddle region encompassing the 16 to 8 kHz band,
and the apical region encompassing the low frequencies between 4
and 0.5 kHz. The outer hair cell counts in the three regions were
conﬁrmed by two blinded subjects and has been represented as
percentage of total OHCs present in Fig. 5B. A signiﬁcant loss of
OHCs was observed in the middle (*P  0.05) and in the base
(***P  0.005) of the cochlea. A profound loss occurred in the
normothermic implanted cochleaewith an average loss of 64% of all
outer hair cells in the basal area, 32.7% in the middle turn and ~10%
in the apex. On the other hand, the hypothermia-treated cochleae
did not show a signiﬁcant loss of OHCs when compared to controls.3.3. Developing a surgical approach for human application
To study the translational potential of this device, we carried out
temperature measurements in cadaver temporal bones using the
current hypothermia probe designed for the rats (Fig. 6, n ¼ 3). The
microthermistor location is shown in Fig. 6A (control, T1). As can be
seen in Fig. 6B, C, the cochlear temperature was reduced gradually
by ~3-6 C within 10minwhile the mastoid cooled by less than 1 C
to equilibrate with room temperature. The cochlear temperature
was maintained near within ±0.5 C, following which a slowochleae normalized with control, contralateral cochleae. The hearing thresholds at each
as assessed (pre-surgery and post-surgical day 1, 3, 7, 14 and 28) are represented. The
Fig. 4. Shows the organ of Corti of chronically implanted rats harvested at Day 28. Stereocilia bundles of HCs were stained with phalloidin-FITC (green) and the nuclei with DAPI
(blue). A) shows the organ of Corti of a hypothermia-treated cochlea undergoing EIT. B) shows an EIT normothermic cochlea that had signiﬁcant outer HC loss (OHC) near the
electrode insertion site indicated by the arrows. C) shows a control, non-operated contralateral cochlea.
Fig. 5. A) shows the hair cell count comparison between outer and inner normo-
thermia treated, hypothermia treated and control cochleae harvested 28 days post
implantation. There was no signiﬁcant inner hair cell loss, but we observed a pro-
nounced outer hair cell loss in normothermic cochleae. B) Quantiﬁcation of the total
number of outer hair cells (OHCs) present at the end of chronic experiment in basal,
middle and apical turn regions of the cochleae in control, normothermic and
hypothermia-treated implanted cochleae. Note the signiﬁcant loss of OHCs in the
middle (*P  0.05) and in the base (***P  0.005) of the normothermic cochlea. Error
bars are S.D.
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baseline levels.
4. Discussion
Previous reports have documented that EIT results in a signiﬁ-
cant loss of residual hair cells either by direct trauma to sensitive
cochlear structures such as basilar membrane, osseous spiral lam-
ina, and modiolus or by cascading molecular effects (Bas et al.,2012; Eshraghi et al., 2013). While it is likely that a combination
of mechanisms is responsible for the loss of residual function,
recent studies have begun to unravel the molecular mechanisms
that underlie the loss of residual hearing. It has been shown that
increased levels of inﬂammation and oxidative stress following
trauma could initiate apoptosis of hair cells. In particular, the mRNA
levels of pro-inﬂammatory cytokines such as TNFa and IL-1b, and
pro-inﬂammatory enzymes, iNOS and COX-2 increased signiﬁ-
cantly following trauma (Bas et al., 2012). Cytokines, such as
interleukin-1 (IL-1) (Touzani et al., 1999) and tumor necrosis factor
alpha (TNF-a) (Dinh et al., 2008; Keithley et al., 2008), are known to
contribute to brain damage similarly to free radicals and may cause
auditory hair cell and spiral ganglion loss. The apoptotic pathways
include the extrinsic or death receptor pathway and the intrinsic or
mitochondrial pathway, with both involving the activation of
caspase-3, which induces chromatin condensation and DNA frag-
mentation (Elmore, 2007).
The feasibility and safety of mild to moderate hypothermia is a
useful therapeutic method for improving recovery from brain in-
juries, strokes, and neural function. Its efﬁcacy has been evaluated
in experimental settings and clinical trials. Previous studies have
assessed the cortical infarct volume and shown that it was signif-
icantly decreased by hypothermic treatment, while others have
identiﬁed an improvement in recovery from spinal cord injury after
intravascular cooling. (Cappuccino et al., 2010; Dietrich et al., 2009;
Kawai et al., 2000; Levi et al., 2010). The neuroprotective mecha-
nisms of hypothermia include suppression of excitotoxicity, free
radical production, neuroinﬂammation, blood brain barrier (BBB)
disruption and regulation of early gene expression. (Darwazeh and
Yan, 2013; Dietrich et al., 2011). Studies have shown that hypo-
thermia related protective effects are also correlated with a sig-
niﬁcant increase in expression of Bcl-2, an important anti-apoptotic
gene, in a rat model of transient global ischemia (Zhang et al., 2010).
Applications of hypothermia in a clinical setting have varied
from systemic hypothermia to localized cooling of surgically
exposed tissue. It has been shown that cochleae undergoing sur-
gical implantation in animals receiving mild hypothermia had less
functional loss compared to normothermic implanted cochlea up to
7 days (Balkany et al., 2005). While the results were positive, the
application of systemic hypothermia for inner ear surgeries is not
clinically feasible. In the present study, we evaluated the potential
of localized hypothermia delivered to the inner ear during cochlear
implant surgery to improve protection of critical structures and
preservation of residual function. The results of the present study
Fig. 6. Shows temperature measurements taken from a human temporal bone during applied hypothermia. (A) shows the placement of the hypothermia probe anteroinferior to the
round window via a myringotomy. The hypothermia probe was placed anteroinferior to the round window via a myringotomy. The temperature was reduced by 4e6 C in on the
bone covering apical surface (via middle fossa approach) (B) and at the round window membrane (C). The mastoid temperature varied less than 1 C during the experiment (D).
I. Tamames et al. / Hearing Research 339 (2016) 32e3938indicate that cooling the inner ear between 4e6 C protected re-
sidual hearing in rats. The hypothermia-treated cochleae showed a
similar but signiﬁcantly smaller shift in the ABR thresholds as the
normothermic-implanted cochleae immediately following the CI.
The ABR thresholds in normothermic-implanted group remained
elevated over the next 4 weeks, while those of the hypothermic-
implanted group recovered starting week 1. Histological results
compared well with the functional data e hypothermic-cochleae
showed signiﬁcant preservation of outer hair cells and minimal
cell death compared to normothermic-cochleae. The approach
utilized a novel copper hypothermia probe attached to a thermo-
electric Peltier device placed under direct visualization in the sur-
gical cavity adjacent to the site of implant. With continuously
circulated refrigerant through the probe tip the temperature of the
cochlea could be reduced by 4e6 C within 5e10min. Furthermore,
the temperature could be maintained within ±0.3 C over the
duration of the experiments. Our approach will be feasible for
human clinical application as shown here and has signiﬁcant ad-
vantages over systemic or external application of hypothermia.
Although the surgical approach and design of our device will need
to be optimized in the future to deliver therapeutic hypothermia to
the human cochleae, these results clearly demonstrated that
effective cooling of the cochlea and inner ear structures is possible.
While the current investigation presents the utility of custom-
designed probe to deliver localized hypothermia in vivo and the
efﬁcacy of hypothermia delivered pre-trauma, several limitations
should be noted. First, the present study focused on normal hearing
animals. The normal functioning cochlea is likely to be different
from a cochlea in a hearing-impaired or deafened animal with
respect to expression of inﬂammatory mediators and may present
different mechanisms of injury not mitigated by therapeutic hy-
pothermia. Second, the auditory function was studied over a rela-
tively short post-implantation period (28 days) and we did not
study potential damage caused by electrical activation of cochlear
implants. It is possible that the protective effects of hypothermia
may have simply delayed the progressive component of the hearing
loss observed following EIT. Additional studies focusing on chronic
effects of EIT, electrical activation and potential beneﬁts of thera-
peutic hypothermia are therefore required prior to translating the
application to clinical trials. Finally, prior literature has shown that
duration of cooling and speed of rewarming can impact the bene-
ﬁcial effects of hypothermia (Polderman and Herold, 2009). In thepresent study, hypothermia was delivered for ~60 min intra-
operatively, with 10 min of cooling and rewarming period and
40 min of maintained hypothermia. The relatively long duration
may restrict widespread adoption of the technique. Future studies
will need to focus on determining the critical duration for thera-
peutic hypothermia applied to the cochlea for CI.
5. Conclusion
In conclusion, the present results are promising and indicate
that therapeutic hypothermia applied pre-trauma protects residual
function in the cochleae following cochlear implantation. In the rat
model, localized hypothermia can reduce the post-implant trauma
and protect the cochleae against the progressive loss of hearing
observed in normothermic implanted cochleae. Additionally, based
on the temporal bone studies described, the present approach ap-
pears to be applicable to patients receiving cochlear implantation
with localized hypothermia achieved during surgery.
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